The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

Diagnostic features of atopic dermatitis

Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086

The Design and Analysis of Clinical Experiments

Fleiss, J. L. (1999) · Wiley eBooks · doi:10.1002/9781118032923 · Cited by 4,819

Severe Psoriasis – Oral Therapy with a New Retinoid

Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718

Severity Scoring of Atopic Dermatitis: The SCORAD Index

(2009) · Dermatology · doi:10.1159/000247298 · Cited by 2,304

Large sample standard errors of kappa and weighted kappa.

Fleiss, J. L., Cohen, J., & Everitt, B. S. (1969) · Psychological Bulletin · doi:10.1037/h0028106 · Cited by 1,536

Grading of the severity of atopic dermatitis.

Rajka, G., & Langeland, T. (1989) · PubMed · doi:10.2340/000155551441314 · Cited by 415

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

Sowden, J. M., Allen, B. R., Berth‐Jones, J., GRAHAM-BROWN, R. A. C., Motley, R., Finlay, A. Y., Salek, S., Marks, R., Ross, J., & Camp, R. D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90134-b · Cited by 411

Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children

Kang, S., Lucky, A. W., Pariser, D. M., Lawrence, I., & Hanifin, J. M. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109812 · Cited by 329

A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients

Paller, A. S., Eichenfield, L. F., Leung, D. Y. M., Stewart, D., & Appell, M. L. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109813 · Cited by 323

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy

Hanifin, J. M., LING, M. R., Langley, R. G. B., Breneman, D., & Rafal, E. S. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109810 · Cited by 285

Omalizumab efficacy in a girl with atopic eczema

Caruso, C., Gaeta, F., Valluzzi, R. L., & Romano, A. G. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02153.x · Cited by 22

Tacrolimus clinical studies for atopic dermatitis and other conditions

Bergman, J. N., & Rico, M. J. (2001) · Seminars in Cutaneous Medicine and Surgery · doi:10.1053/sder.2001.29061 · Cited by 22

Efficacy and action mechanisms of a Chinese herbal formula on experimental models of atopic dermatitis

Wang, L., Xian, Y., Hu, Z. J., Loo, S. K. F., Ip, S., Chan, W. Y., Lin, Z., & Wu, J. C. Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114021 · Cited by 23

Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks

Blauvelt, A., de Bruin-Weller, M. S., Simpson, E. L., Chen, Z., Zhang, A., & Shumel, B. S. (2021) · Dermatology and Therapy · doi:10.1007/s13555-021-00638-1 · Cited by 21

Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP)

Galli, E., Fortina, A. B., Ricci, G., Maiello, N., Neri, I., Baldo, E., Berti, I., Bonamonte, D., Capra, L., Carboni, E., et al. (2022) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-022-01278-7 · Cited by 21

Comprehensive Genomic Characterization of Staphylococcus aureus Isolated from Atopic Dermatitis Patients in Japan: Correlations with Disease Severity, Eruption Type, and Anatomical Site

Obata, S., Hisatsune, J., Kawasaki, H., Fukushima‐Nomura, A., Ebihara, T., Arai, C., Masuda, K., Kutsuno, S., Iwao, Y., Sugai, M., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.05239-22 · Cited by 21

Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study

Merola, J. F., Chiou, A. S., During, E., Costanzo, A., Foley, P. A., AlFalasi, A. A., Gogate, S. U., Pinter, A., Dodiuk‐Gad, R. P., Simon, D., et al. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad284 · Cited by 21

Gender differences in adult atopic dermatitis and clinical implication: Results from a nationwide multicentre study

Marani, A., Bianchelli, T., Gesuita, R., Faragalli, A., Foti, C., Malara, G., Micali, G., Amerio, P., Rongioletti, F., Corazza, M., et al. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19580 · Cited by 21

Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis

Simpson, E. L., de Bruin-Weller, M. S., Hong, H., Staumont-Sallé, D., Blauvelt, A., Eyerich, K., Gooderham, M., Shahriari, M., Mallbris, L., Atwater, A. R., et al. (2024) · Dermatology and Therapy · doi:10.1007/s13555-024-01158-4 · Cited by 21

The Anti‐Inflammatory Effect of Fructus Kochiae on Allergic Contact Dermatitis Rats via pERK1/2/TLR4/NF‐κB Pathway Activation

Xiao, Z., Xiao, S., Yongning, Z., Pan, T., & Ouyang, B. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/1096920 · Cited by 21

Base and Covariate Population Pharmacokinetic Analyses of Dupilumab Using Phase 3 Data

Kovalenko, P., Davis, J. D., Li, M., Rippley, R. K., Ardeleanu, M., Shumel, B. S., Graham, N. M. H., Pirozzi, G., Kamal, M. A., & DiCioccio, A. T. (2020) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.780 · Cited by 21

Anti-inflammatory Effects of Achillea millefolium on Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice

Ngo, H. T. T., Hwang, E., Kang, H., Park, B., Seo, S. A., & Yi, T. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x2050055x · Cited by 21

‘EASIdig’ – A Digital Tool to Document Disease Activity in Atopic Dermatitis

Tremp, M., Knafla, I., Burg, G., Wüthrich, B., & Schmid‐Grendelmeier, P. (2011) · Dermatology · doi:10.1159/000330333 · Cited by 21

Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel®) for up to 1 year

van Leent, E. J. M., de Vries, H. J. C., Ebelin, M., Burtin, P., Scott, G., & Bos, J. D. (2007) · Journal of Dermatological Treatment · doi:10.1080/09546630601121037 · Cited by 21

A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis.

Lebwohl, M., & Gower, T. (2006) · PubMed Central · Cited by 21

Treatment of Atopic Dermatitis with a Low-histamine Diet

Chung, B. Y., Cho, S. I., Ahn, I. S., Lee, H. B., Kim, H. O., Park, C. W., & Lee, C. H. (2011) · Annals of Dermatology · doi:10.5021/ad.2011.23.s1.s91 · Cited by 21

The evolving atopic dermatitis management landscape

Sahni, V. N., Balogh, E. A., Strowd, L. C., & Feldman, S. R. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1999412 · Cited by 20

Rituximab as a treatment for severe atopic eczema: failure to improve in three consecutive patients

McDonald, B., Jones, J. L., & Rustin, M. H. A. (2015) · Clinical and Experimental Dermatology · doi:10.1111/ced.12691 · Cited by 20

Nail Dystrophy in Patients with Atopic Dermatitis and Its Association with Disease Severity

Chung, B. Y., Choi, Y. W., Kim, H. O., & Park, C. W. (2019) · Annals of Dermatology · doi:10.5021/ad.2019.31.2.121 · Cited by 20

Measurement properties of the Patient-Reported Outcomes Measurement Information System Itch Questionnaire item banks in adults with atopic dermatitis

Silverberg, J. I., Lai, J., Vakharia, P. P., Patel, K. R., Singam, V., Chopra, R., Sacotte, R. M., Patel, N., Rastogi, S., Kantor, R. W., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.11.057 · Cited by 20

Dupilumab in Elderly Patients With Severe Atopic Dermatitis

Russo, F., Milanesi, N., Cartocci, A., Bruzziches, F., Tronconi, G., Lazzeri, L., D’Erme, A. M., Bagnoni, G., Gola, M., Cinotti, É., et al. (2020) · Dermatitis · doi:10.1097/der.0000000000000686 · Cited by 20

Filaggrin gene polymorphisms are associated with atopic dermatitis in women but not in men in the Caucasian population of Central Russia

Dvornyk, V., Ponomarenko, I., Belyaeva, T. M., Александрович, Р. Е., & Churnosov, M. I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261026 · Cited by 20

IgG from Adult Atopic Dermatitis (AD) Patients Induces Nonatopic Neonatal Thymic Gamma–Delta T Cells (γδT) to Acquire IL-22/IL-17 Secretion Profile with Skin-Homing Properties and Epigenetic Implications Mediated by miRNA

Fagundes, B. O., de Sousa, T. R., Nascimento, A., Fernandes, L. A., Sgnotto, F. D. R., Orfali, R. L., Aoki, V., Duarte, A. J. D. S., Sanabani, S. S., & Victor, J. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126872 · Cited by 20

Effects of topical corticosteroid versus tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis—A randomized controlled study

Gether, L., Storgaard, H., Kežić, S., Jakaša, I., Hartmann, B., Skov‐Jeppesen, K., Holst, J. J., Pedersen, A. J., Forman, J. L., van Hall, G., et al. (2023) · Allergy · doi:10.1111/all.15690 · Cited by 20

Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis

Achten, R., van der Rijst, L. P., Piena, M. A., Lamers, H., de Beer, F. S. A., de Bruin-Weller, M. S., & de Graaf, M. (2023) · Acta Dermato Venereologica · doi:10.2340/actadv.v103.4842 · Cited by 21

Perception‐based 3D tactile rendering from a single image for human skin examinations by dynamic touch

Kim, K., & Lee, S. (2014) · Skin Research and Technology · doi:10.1111/srt.12173 · Cited by 20

Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry

Siegfried, E. C., Jaworski, J. C., Eichenfield, L. F., Paller, A. S., Hebert, A. A., Simpson, E. L., Altman, E., Arena, C., Blauvelt, A., Block, J. K., et al. (2018) · Pediatric Dermatology · doi:10.1111/pde.13452 · Cited by 20

Clinical Management of Atopic Dermatitis in Adults: Mapping of Expert Opinion in 4 Nordic Countries using a Modified Delphi Process

Thyssen, J. P., Berents, T. L., Bradley, M., Deleuran, M. S., Grimstad, Ø., Korhonen, L., Langeland, T., Särnhult, T., Thomsen, S. F., Thune, T., et al. (2019) · Acta Dermato Venereologica · doi:10.2340/00015555-3369 · Cited by 20

Measurement properties of the product of investigator’s global assessment and body surface area in children and adults with atopic dermatitis

Silverberg, J. I., Lei, D. K., Yousaf, M., Janmohamed, S. R., Vakharia, P. P., Chopra, R., Chavda, R., Gabriel, S., Patel, K. R., Singam, V., et al. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16846 · Cited by 20

The Unmet Needs in Atopic Dermatitis Control in Latin America: A Multidisciplinary Expert Perspective

Sánchez, J., Chérrez-Ojeda, I., Galván, C. A., García, E., Hernández-Mantilla, N., Londoño, Á., McElwee, E., Rico-Restrepo, M., Rivas, E., & Hidalgo, B. (2021) · Dermatology and Therapy · doi:10.1007/s13555-021-00595-9 · Cited by 20

The new scoring system for evaluation of skin inflammation extent and severity in patients with atopic dermatitis.

Silny, W., Czarnecka-Operacz, M. M., & Silny, P. (2005) · PubMed · Cited by 20

Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial

Spergel, J. M., Boguniewicz, M., Paller, A. S., Hebert, A. A., Gallagher, P. R., McCormick, C. L., Parneix‐Spake, A., & Hultsch, T. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08001.x · Cited by 20

Recent Advances in Treatment Strategies for Atopic Dermatitis

Roos, T. C., Geuer, S., Roos, S., & Brost, H. (2004) · Drugs · doi:10.2165/00003495-200464230-00003 · Cited by 20

Severity of atopic dermatitis is associated with gut-derived metabolites and leaky gut-related biomarkers

Blicharz, L., Samborowska, E., Zagożdżon, R., Bukowska‐Ośko, I., Czuwara, J., Zych, M., Roszczyk, A., Perlejewski, K., Makowska, K., Nowaczyk, J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-09520-y · Cited by 19

Patient-reported outcomes for measuring sleep disturbance in pediatric atopic dermatitis: Cross-sectional study of the Patient Reported Outcomes Measurement Information System pediatric sleep measures and actigraphy

Fishbein, A. B., Lor, J., Penedo, F. J., Forrest, C. B., Griffith, J. W., & Paller, A. S. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.05.138 · Cited by 19

Derma-Hc, a New Developed Herbal Formula, Ameliorates Cutaneous Lichenification in Atopic Dermatitis

Nam, Y. K., Kim, M. H., Ha, I. J., & Yang, W. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052359 · Cited by 19

Advanced In Vitro Three-Dimensional Skin Models of Atopic Dermatitis

Jang, H., Lee, J. B., & Yoon, J. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-023-00532-1 · Cited by 22

Reliable Detection of Eczema Areas for Fully Automated Assessment of Eczema Severity from Digital Camera Images

Attar, R., Hurault, G., Wang, Z., Mokhtari, R., Pan, K., Olabi, B., Earp, E., Steele, L., Williams, H. C., & Tanaka, R. J. (2023) · JID Innovations · doi:10.1016/j.xjidi.2023.100213 · Cited by 19

Itch, sleep loss, depressive symptoms, fatigue, and productivity loss in patients with moderate‐to‐severe atopic dermatitis: Analyses of TREATgermany registry data

Birkner, T., Siegels, D., Heinrich, L., Haufe, E., Abraham, S., Heratizadeh, A., Harder, I., Bell, M., Fell, I., Worm, M., et al. (2023) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.15159 · Cited by 19

Recent trends of ocular complications in patients with atopic dermatitis

Yamamoto, K., Wakabayashi, Y., 川上, 摂., Numata, T., Ito, T., Okubo, Y., Tsuboi, R., & Gotô, H. (2019) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-019-00678-3 · Cited by 19

Improving patient education for atopic dermatitis: A randomized controlled trial of a caregiver handbook

LeBovidge, J., Timmons, K. G., Delano, S., Greco, K. F., DeFreitas, F., Chan, F., Jeong, T., Rosen, M. H., Rea, C. J., & Schneider, L. C. (2021) · Pediatric Dermatology · doi:10.1111/pde.14519 · Cited by 19

Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older.

Simpson, E. L., Paller, A. S., Siegfried, E. C., Thaçi, D., Wollenberg, A., Cork, M. J., Marcoux, D., Huang, R., Chen, Z., Rossi, A. B., et al. (2021) · Europe PMC (PubMed Central) · doi:10.1007/s13555-021-00568-y · Cited by 19

Genome of Malassezia arunalokei and Its Distribution on Facial Skin

Cho, Y., Kim, T., Croll, D., Park, M., Kim, D., Keum, H. L., Sul, W. J., & Jung, W. H. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00506-22 · Cited by 19

Prototype tactile feedback system for examination by skin touch

Lee, O., Lee, K., Oh, C. H., Kim, K., & Kim, M. G. (2013) · Skin Research and Technology · doi:10.1111/srt.12120 · Cited by 19

Disseminated bullous impetigo and atopic dermatitis: Case series and literature review

Mannschreck, D. B., Feig, J. L., Selph, J., & COHEN, B. A. (2019) · Pediatric Dermatology · doi:10.1111/pde.14032 · Cited by 19

Pimecrolimus cream 1% is effective in asteatotic eczema: results of a randomized, double‐blind, vehicle‐controlled study in 40 patients

Schulz, P. J., Bunselmeyer, B., Bräutigam, M., & Luger, T. (2006) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2006.01879.x · Cited by 19

Dendritic cells produce inflammatory cytokines in response to bacterial products from Staphylococcus aureus-infected atopic dermatitis lesions

Voorhees, T. J., Chang, J., Yao, Y., Kaplan, M. H., Chang, C., & Travers, J. B. (2010) · Cellular Immunology · doi:10.1016/j.cellimm.2010.10.010 · Cited by 19

Nail manifestations in atopic dermatitis: a systematic review

Chng, W. Q., & Yew, Y. W. (2019) · International Journal of Dermatology · doi:10.1111/ijd.14726 · Cited by 18

Assessing uptake of the Harmonising Outcome Measures for Eczema (HOME) Core Outcome Set and recommended instruments

Vincent, R., Chalmers, J. R., McWilliams, C., Thomas, K. S., Dodd, S. R., Rogers, N. K., Ridd, M. J., Schmitt, J. M., & Kirkham, J. J. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19030 · Cited by 18

Treatment options for moderate to severe atopic dermatitis

Wallace, D. V. (2022) · Allergy and Asthma Proceedings · doi:10.2500/aap.2022.43.220076 · Cited by 18

Raster-scanning optoacoustic mesoscopy biomarkers for atopic dermatitis skin lesions

Nau, T., Schönmann, C., Hindelang, B., Riobó, L. M., Doll, A., Schneider, S., Englert, L., He, H., Biedermann, T., Darsow, U. G., et al. (2023) · Photoacoustics · doi:10.1016/j.pacs.2023.100513 · Cited by 18

Impact of Topical Calcineurin Inhibitors on Quality of Life in Patients with Atopic Dermatitis

Ingram, J. R., Martin, J. A., & Finlay, A. Y. (2009) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200910040-00003 · Cited by 18

Assessing the reliability of four severity scales depicting skin ageing features

Valet, F., Ezzedine, K., Malvy, D. J.-M., Mary, J. Y., & Guinot, C. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09148.x · Cited by 18

Importance of concomitant topical therapy in moderate-to-severe atopic dermatitis treated with cyclosporine

Kim, J. E., Shin, J. M., Ko, J. Y., & Ro, Y. S. (2016) · Dermatologic Therapy · doi:10.1111/dth.12333 · Cited by 18

Current therapeutic paradigm in pediatric atopic dermatitis: Practical guidance from a national expert panel

Chiricozzi, A., Fortina, A. B., Galli, E., Girolomoni, G., Neri, I., Ricci, G., Romanelli, M., & Peroni, D. G. (2018) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2018.06.008 · Cited by 18

Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults: A pooled analysis of two phase 2 clinical trials

Tofte, S. J., Papp, K. A., Sadick, N. S., Bohnert, K. L., Simpson, E. L., Thaçi, D., Bieber, T. R. M., Blauvelt, A., Sofen, H. L., Gooderham, M., et al. (2018) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000088 · Cited by 18

Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab

Nakahara, T., Izuhara, K., Onozuka, D., Nunomura, S., Tamagawa‐Mineoka, R., Masuda, K., Ichiyama, S., Saeki, H., Kabata, Y., Abe, R., et al. (2020) · Medicine · doi:10.1097/md.0000000000022043 · Cited by 19

Measurement Properties of Patient Health Questionnaire 9 and Patient Health Questionnaire 2 in Adult Patients with Atopic Dermatitis

Silverberg, J. I., Lee, B., Lei, D. K., Yousaf, M., Janmohamed, S. R., Vakharia, P. P., Chopra, R., Chavda, R., Gabriel, S., Patel, K. R., et al. (2020) · Dermatitis · doi:10.1097/der.0000000000000653 · Cited by 18

Instrumental evaluation of skin barrier function and clinical outcomes during dupilumab treatment for atopic dermatitis: An observational study

Cristaudo, A., Pigliacelli, F., Sperati, F., Orsini, D., Cameli, N., Morrone, A., & Mariano, M. (2021) · Skin Research and Technology · doi:10.1111/srt.13025 · Cited by 18

Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3)

Simpson, E. L., Wollenberg, A., Soong, W., Steffensen, L. A., Kurbasic, A., Schneider, S. K. R., Zoidis, J., & Silverberg, J. I. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.07.007 · Cited by 18

Effective Treatment of Facial Redness Caused by Atopic Dermatitis Using Intense Pulsed Light Systems

Oh, S. H., Bae, B. K., Kim, T., Kwon, Y. S., Lee, J. H., & Lee, K. H. (2010) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2010.01482.x · Cited by 18

Evaluation of patient's subjective severity using various scoring system in Korean children with atopic dermatitis.

Yang, H. J., Jeon, Y. H., & Pyun, B. Y. (2010) · PubMed · Cited by 18

Measurement properties of the Rajka–Langeland severity score in children and adults with atopic dermatitis*

Silverberg, J. I., Lei, D. K., Yousaf, M., Janmohamed, S. R., Vakharia, P. P., Chopra, R., Chavda, R., Gabriel, S., Patel, K. R., Singam, V., et al. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19159 · Cited by 18

Odontogenic focal infection could be partly involved in the pathogenesis of atopic dermatitis as exacerbating factor

Igawa, K., Nishioka, K., & Yokozeki, H. (2007) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2007.03101.x · Cited by 18

Steroids versus other immune modulators in the management of allergic dermatoses

Abramovits, W., & Perlmutter, A. (2006) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/01.all.0000244795.41357.6e · Cited by 18

Calcineurin inhibitors in the treatment of allergic dermatitis

Castro, A. P. B. M. (2006) · Jornal de Pediatria · doi:10.2223/jped.1557 · Cited by 18

Efficacy and Safety of Once‐Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2–5 Years With Mild‐to‐Moderate Atopic Dermatitis ( INTEGUMENT ‐ PED ): A Phase 3 Randomized Controlled Trial

Eichenfield, L. F., Serrao, R. T., Prajapati, V. H., Browning, J. C., Swanson, L., Funk, T., González, M. E., Hebert, A. A., Lee, M. S., Boguniewicz, M., et al. (2025) · Pediatric Dermatology · doi:10.1111/pde.15840 · Cited by 17

Early transcriptional changes after UVB treatment in atopic dermatitis include inverse regulation of IL‐36γ and IL‐37

Lossius, A. H., Berents, T. L., Sætre, F., Nilsen, H. R., Bradley, M., Asad, S., Haraldsen, G., Sundnes, O., & Holm, J.-Ø. (2020) · Experimental Dermatology · doi:10.1111/exd.14217 · Cited by 17

DESCRIBE-AD: A novel classification framework for atopic dermatitis

Chovatiya, R., & Silverberg, J. I. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.10.058 · Cited by 17

Taiwan guidelines for the diagnosis and management of pediatric atopic dermatitis: Consensus statement of the Taiwan Academy of Pediatric Allergy, Asthma and Immunology

Yao, T., Wang, I., Sun, H., Ou, L.-S., Yu, H., Wang, L., & Hung, C. (2022) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2022.03.004 · Cited by 17

Biosignatures of defective sebaceous gland activity in sebum‐rich and sebum‐poor skin areas in adult atopic dermatitis

Cavallo, A., Camera, E., Bottillo, G., Maiellaro, M., Truglio, M., Marini, F., Chavagnac‐Bonneville, M., Fauger, A., Perrier, É., Pigliacelli, F., et al. (2024) · Experimental Dermatology · doi:10.1111/exd.15066 · Cited by 17

Choice of Moisturiser for Eczema Treatment (COMET): study protocol for a randomized controlled trial

Ridd, M. J., Redmond, N. M., Hollinghurst, S. P., Ball, N., Shaw, L., Guy, R. H., Wilson, V. J., Metcalfe, C. D., & Purdy, S. (2015) · Trials · doi:10.1186/s13063-015-0830-y · Cited by 17

Pruni cortex ameliorates skin inflammation possibly through HMGB1-NFκB pathway in house dust mite induced atopic dermatitis NC/Nga transgenic mice

Watanabe, K., Karuppagounder, V., Arumugam, S., Thandavarayan, R. A., Pitchaimani, V., Sreedhar, R., Afrin, R., Harima, M., Suzuki, H., Suzuki, K., et al. (2015) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.14-75 · Cited by 17

Atopic Dermatitis and the Atopic March: What Is New?

Patrizi, A., Pileri, A., Bellini, F., Raone, B., Neri, I., & Ricci, G. (2011) · Journal of Allergy · doi:10.1155/2011/279425 · Cited by 17

Change in Quality of Life according to the Change in Atopic Dermatitis Severity

Cho, J., Lee, J. H., Suh, J., Yu, J. S., Lee, H., Park, E., Kim, H., Chang, E. Y., Kim, J., Han, Y., et al. (2012) · Pediatric Allergy and Respiratory Disease · doi:10.7581/pard.2012.22.1.86 · Cited by 17

Management of Atopic Dermatitis in Japan

Saeki, H. (2017) · Journal of Nippon Medical School · doi:10.1272/jnms.84.2 · Cited by 17

Diagnosing atopic dermatitis in infancy: Questionnaire reports vs criteria‐based assessment

Dharma, C., Lefebvre, D. L., Tran, M. M., Lu, Z., Lou, W. Y. W., Subbarao, P., Becker, A. B., Mandhane, P. J., Turvey, S. E., Moraes, T. J., et al. (2018) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12525 · Cited by 17

Effects of Merino Wool on Atopic Dermatitis Using Clinical, Quality of Life, and Physiological Outcome Measures

Fowler, J. F., Fowler, L. M., & Lorenz, D. J. (2019) · Dermatitis · doi:10.1097/der.0000000000000449 · Cited by 17

Management of Atopic Dermatitis in Children Younger Than Two Years of Age by Community Pediatricians: A Survey and Chart Review

Fishbein, A. B., Hamideh, N., Lor, J., Zhao, S., Kruse, L. L., Mason, M., Ariza, A. J., Bolaños, L., Necheles, J., & Kaye, B. A. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.02.015 · Cited by 17

Increased level of high mobility group box 1 in the serum and skin in patients with generalized pustular psoriasis

Watanabe, T., Yamaguchi, Y., Watanabe, Y., Takamura, N., & Aihara, M. (2020) · The Journal of Dermatology · doi:10.1111/1346-8138.15467 · Cited by 17

Hypnosis in Treatment of Atopic Dermatitis: A Clinical Study

Delaitre, L., Denis, J., & Maillard, H. (2020) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207144.2020.1788391 · Cited by 17

The potential pathways underlying the association of propyl-paraben exposure with aeroallergen sensitization and EASI score using metabolomics analysis

Lee, Y., Lee, E. M., Yon, D. K., Jee, H. M., Baek, H., Lee, S. W., Cho, J., & Han, M. Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-83288-9 · Cited by 17

Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry

Ariëns, L. F. M., Bakker, D. S., Spekhorst, L. S., van der Schaft, J., Thijs, J. L., Haeck, I. M., Flinterman, A. E., Kamsteeg, M., Schuttelaar, M. L. A., & de Bruin-Weller, M. S. (2021) · Acta Dermato Venereologica · doi:10.2340/00015555-3886 · Cited by 17

IGAxBSA composite for assessing disease severity and response in patients with atopic dermatitis*

Paller, A. S., Tan, J. K. L., Bagel, J., Rossi, A. B., Shumel, B. S., Zhang, H., & Abramova, A. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20872 · Cited by 17

Dose-Dependent Effects of Evening Primrose Oil in Children and Adolescents with Atopic Dermatitis

Chung, B. Y., Kim, J. H., Cho, S. I., Ahn, I. S., Kim, H. O., Park, C. W., & Lee, C. H. (2013) · Annals of Dermatology · doi:10.5021/ad.2013.25.3.285 · Cited by 17

Expression patterns of atopic eczema and respiratory illnesses in a high-risk birth cohort

Singh, A. M., Evans, M. D., Gangnon, R. E., Roberg, K. A., Tisler, C. J., DaSilva, D. F., Pappas, T., Salazar, L. E. P., Anderson, E. L., Gern, J. E., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.11.026 · Cited by 17

DOCK8: regulator of Treg in response to corticotropin-releasing hormone

Jin, S., Shin, J. U., Noh, J. Y., Kim, H., Kim, J. Y., Kim, S. H., Kim, J. H., Park, C. O., Lee, N., Lee, H., et al. (2016) · Allergy · doi:10.1111/all.12845 · Cited by 17

Clinical characteristics of Korean patients with filaggrin-related atopic dermatitis

Park, K. Y., Park, M. K., Seok, J., Li, K., & Seo, S. J. (2016) · Clinical and Experimental Dermatology · doi:10.1111/ced.12854 · Cited by 17

Formulary Review of Therapeutic Alternatives for Atopic Dermatitis: Focus on Pimecrolimus

Weinberg, J. M. (2005) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2005.11.1.56 · Cited by 17

Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial

Simpson, E. L., Eichenfield, L. F., Papp, K. A., Forman, S. B., Hebert, A. A., González, M. E., Gooderham, M., Hong, H., Prajapati, V. H., Guttman‐Yassky, E., et al. (2025) · Dermatitis · doi:10.1089/derm.2024.0418 · Cited by 16

Evaluation of the levels of interleukins IL-4, IL-13, IL-5, IL-10 and IL-33 in atopic dermatitis patients with and without dupilumab therapy

Čelakovská, J., Čermáková, E., Boudková, P., & Krejsek, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1604883 · Cited by 16

Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis

Augustin, M., Bauer, A., Ertner, K., von Kiedrowski, R., Schenck, F., Ramaker‐Brunke, J., Möller, S., Fait, A., Bastian, M., & Thaçi, D. (2023) · Dermatology and Therapy · doi:10.1007/s13555-023-00894-3 · Cited by 16

Off-label use of Baricitinib improves moderate and severe atopic dermatitis in China through inhibiting MAPK and PI3K/Akt/mTOR pathway via targeting JAK-STAT signaling of CD4+ cells

Chen, S., Li, C., Tu, Z., Cai, T., Zhang, X., Wang, L., Tian, R., Huang, J., Gong, Y., Yang, X., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1324892 · Cited by 16

Expression of Staphylococcus aureus Virulence Factors in Atopic Dermatitis

Poh, S. E., Koh, W. L. C., Lim, S. Y. D., Wang, E. C. E., Yew, Y. W., Common, J., Oon, H. H. B., & Li, H. (2022) · JID Innovations · doi:10.1016/j.xjidi.2022.100130 · Cited by 16

Encoding a superantigen by Staphylococcus aureus does not affect clinical characteristics of infected atopic dermatitis lesions

Kozman, A., Yao, Y., Bina, P., Saha, C., Yao, W., Kaplan, M. H., & Travers, J. B. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09966.x · Cited by 16

Evaluation of human thymus and activation-regulated chemokine concentrations in blood using a new sandwich ELISA based on monoclonal antibodies

Morita, A., Kikuoka, S., Horikawa, T., Bito, T., Yamada, H., Kanda, M., Sasakura, K., Tamaki, M., Hirai, K., Suzuki, R., et al. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00131-6 · Cited by 16

Association between a common IL10 distal promoter haplotype and IgE production in individuals with atopic dermatitis

Lacy, K. E., Archer, C., Wood, N., & Bidwell, J. L. (2009) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2009.00857.x · Cited by 16

"Objective" Measures of Atopic Dermatitis Severity

Williams, H. C. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.11.1490 · Cited by 16

Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD)

de Bruin-Weller, M. S., Pink, A., Ferrucci, S. M., Patrizi, A., Svensson, Å., Schuttelaar, M. L. A., Tauber, M., Ardeleanu, M., Jayawardena, S., & Daoud, M. (2022) · Journal of Dermatological Treatment · doi:10.1080/09546634.2022.2038361 · Cited by 15

EczemaPred: A computational framework for personalised prediction of eczema severity dynamics

Hurault, G., Stalder, J. F., Méry, S., Delarue, A., Aroman, M. S., Josse, G., & Tanaka, R. J. (2022) · Clinical and Translational Allergy · doi:10.1002/clt2.12140 · Cited by 15

Interobserver Agreement of the Eczema Area and Severity Index for Atopic Dermatitis Severity Assessment: A Real-World Evidence Study

Villa-González, J. M., Gonzalez-Hermosa, M. R., Alzaga, J. U., Blasco, R. P., Ibarrola, P. A., Atxutegi‐Ayesta, X., García, A. G., Aguirre, I. I., del Tánago, B. U. G., Ares, M. P., et al. (2025) · Dermatitis · doi:10.1089/derm.2025.0054 · Cited by 2

What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study

Leshem, Y. A., Hajar, T., Hanifin, J. M., & Simpson, E. L. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13662 · Cited by 295

How Adequately is the Severity of Atopic Dermatitis Assessed by Resident Physicians Training in Dermatology? Evaluation of the Intrarater and Interrater Reliability of Clinical Scoring Systems (EASI, oSCORAD, IGA, TIS Score, SASSAD)

Waligóra-Dziwak, K., Kubiak, K. B., Dańczak‐Pazdrowska, A., & Jenerowicz, D. (2026) · Acta Dermato Venereologica · doi:10.2340/actadv.v106.43964 · Cited by 1

Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA

Bożek, A., & Reich, A. (2017) · Dermatology · doi:10.1159/000472711 · Cited by 74

The Atopic Dermatitis Antecubital Severity score: validity, reliability, and sensitivity to change in patients with atopic dermatitis

Baek, J. H., Park, C. W., Choi, K. M., Yang, Y. S., Lee, S. Y., Koh, J. S., Chung, B. Y., Kim, H. O., & Park, G. (2014) · International Journal of Dermatology · doi:10.1111/ijd.12711 · Cited by 11